BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2576360)

  • 1. Pharmacokinetics of picumast dihydrochloride in patients with liver cirrhosis.
    Neugebauer G; Raedsch R; Stiehl A; Kaufmann B; Besenfelder E; Neubert P; Walter-Sack I
    Arzneimittelforschung; 1989 Oct; 39(10A):1343-7. PubMed ID: 2576360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of picumast dihydrochloride and its active metabolites M1 and M2 in humans.
    Neugebauer G; Wittenbrink-Dix AM; Woelke-Seidl E; Kaufmann B; Ponton T; Dahmen W; Mosberg H; Nieder N; Besenfelder E
    Arzneimittelforschung; 1989 Oct; 39(10A):1336-9. PubMed ID: 2576358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of potential kinetic interactions of picumast dihydrochloride and theophylline in vitro and after oral administration in man.
    Wittenbrink-Dix AM; Neugebauer G; Fuhr U; Neubert P; Besenfelder E; Woelke-Seidl E; Harder S; Staib AH
    Arzneimittelforschung; 1989 Oct; 39(10A):1339-43. PubMed ID: 2576359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of picumast after administration of 14C-picumast dihydrochloride in dogs, rats, rabbits and monkeys.
    Schaumann W; Besenfelder E; Boehm E; Neubert P; Roesch A; Sterz H
    Arzneimittelforschung; 1989 Oct; 39(10A):1321-7. PubMed ID: 2576356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A one-year double-blind clinical study of the efficacy and tolerability of picumast dihydrochloride versus ketotifen in patients with bronchial asthma.
    Slapke J; Müller S; Boerner D
    Arzneimittelforschung; 1989 Oct; 39(10A):1368-72. PubMed ID: 2576366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind multicenter controlled clinical study comparing the efficacy of picumast dihydrochloride versus astemizole and placebo in patients with seasonal allergic rhinitis.
    Franke W; Messinger D
    Arzneimittelforschung; 1989 Oct; 39(10A):1360-3. PubMed ID: 2576364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
    Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H
    Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of picumast dihydrochloride in comparison with placebo in asthmatic patients.
    Boerner D; Metz K; Eberhardt R
    Arzneimittelforschung; 1989 Oct; 39(10A):1363-7. PubMed ID: 2576365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of picumast dihydrochloride on antigen-induced early and late airway responses in allergic sheep.
    Abraham WM
    Arzneimittelforschung; 1989 Oct; 39(10A):1328-31. PubMed ID: 2576357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of picumast dihydrochloride on the ex vivo histamine release from leucocytes of allergic asthmatic patients.
    Zimmermann I; Roesch A; Ulmer WT
    Arzneimittelforschung; 1989 Oct; 39(10A):1351-3. PubMed ID: 2483313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 2nd communication: distribution and transfer into the fetus and milk after a single intravenous administration and pharmacokinetics and enzyme induction after repeated intravenous administration to rats.
    Sugimoto T; Hayashi T; Okita A; Morino A
    Arzneimittelforschung; 1996 Feb; 46(2):114-27. PubMed ID: 8720299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A placebo-controlled comparison of the efficacy and tolerability of picumast dihydrochloride and terfenadine in patients with seasonal allergic rhinitis.
    Boerner D; Metz K; Eberhardt R; Schürmann W
    Arzneimittelforschung; 1989 Oct; 39(10A):1356-9. PubMed ID: 2576363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind study on the influence of picumast dihydrochloride on safety-related performance.
    Herberg KW
    Arzneimittelforschung; 1989 Oct; 39(10A):1348-51. PubMed ID: 2576361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of picumast after administration of picumast dihydrochloride and antiallergic activity of the main metabolites.
    Besenfelder E; Neubert P; Roesch A; Schaumann W; Wilhelms OH
    Arzneimittelforschung; 1989 Oct; 39(10A):1317-20. PubMed ID: 2576355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiallergic activity of picumast dihydrochloride in several animal species.
    Roesch A; Schaumann W; Wilhelms OH
    Arzneimittelforschung; 1989 Oct; 39(10A):1310-6. PubMed ID: 2576354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of pharmacokinetics of M1, M2, M3, and M4 after intravenous administration of DA-125 or ME2303 to mice and rats. New adriamycin analogues containing fluorine.
    Yoon EJ; Lee WI; Shim HJ; Lee SD; Kim WB; Yang J; Lee MG
    Biopharm Drug Dispos; 1996 Jul; 17(5):373-420. PubMed ID: 8830976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acceptability, safety and efficacy of picumast dihydrochloride on long-term use in patients with perennial bronchial asthma.
    Boerner D; Metz K; Eberhardt R
    Arzneimittelforschung; 1989 Oct; 39(10A):1372-4. PubMed ID: 2576367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and pharmacodynamics of the acetylcholinesterase inhibitor 2,2,2-trifluoro-1-(3-trimethylsilylphenyl) ethanone in dog. Potential for transdermal patch delivery.
    Dow J; Dulery BD; Hornsperger JM; Di Francesco GF; Keshary P; Haegele KD
    Arzneimittelforschung; 1995 Dec; 45(12):1245-52. PubMed ID: 8595078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind controlled crossover study comparing the protective effect of picumast dihydrochloride versus placebo following nasal allergen challenge.
    Franke W; Bachert C; Messinger D
    Arzneimittelforschung; 1989 Oct; 39(10A):1354-6. PubMed ID: 2576362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biotransformation and uric acid lowering effect of benzbromarone in patients with liver cirrhosis - evidence for active benzbromarone metabolites?
    Walter-Sack I; de Vries JX; von Bubnoff A; Pfleilschifter V; Raedsch R
    Eur J Med Res; 1995 Oct; 1(1):16-20. PubMed ID: 9392688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.